Levee Medical
Durham, US · Founded 2018 · Delaware corporation
Levee Medical develops the Voro Urologic Scaffold, an absorbable medical device designed to reduce urinary incontinence in men following radical prostatectomy for prostate cancer. The device is in the research and development phase and not yet approved for sale.
Founders & leadership
BC
Bruce ChoiinFounder, Director, CTO & Chairman
AI
Adam IrvingCEO & Director
Board
PM
Peter MulrooneyBoard director
GM
Gary McCordBoard director
Reported raises · per SEC filings
Form D private placements$28.3M disclosed across 5 rounds · 2021–2025
▶$12.5MraisedMay 2026 · 130 investors · Other Health CareRule 506(b)
▶$12.5MraisedMay 2026 · 130 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter MulrooneyDirector
- Bruce ChoiExecutive Officer, Director
- Gary McCordDirector
- Mike HensonDirector
- Adam IrvingExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $12.5M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedAug 2024 · 70 investors · Other Health CareRule 506(b)
▶$6.5MraisedAug 2024 · 70 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce ChoiExecutive Officer, Director
- Adam IrvingExecutive Officer, Director
- Peter MulrooneyDirector
- Gary McCordDirector
- Offering amount
- $10M
- Amount sold
- $6.5M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedJul 2023 · 34 investors · Other Health CareRule 506(b)
▶$3.4MraisedJul 2023 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam IrvingExecutive Officer, Director
- Peter MulrooneyDirector
- Bruce ChoiExecutive Officer, Director
- Gary McCordDirector
- Offering amount
- $4.3M
- Amount sold
- $3.4M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedJul 2022 · 54 investors · Other Health CareRule 506(b)
▶$3.3MraisedJul 2022 · 54 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce ChoiExecutive Officer, Director
- Gary McCordDirector
- Peter MulrooneyDirector
- Adam IrvingExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.3M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.6MraisedJan 2022 · 49 investors · Other Health CareRule 506(b)
▶$2.6MraisedJan 2022 · 49 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce ChoiExecutive Officer, Director
- Adam IrvingExecutive Officer
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapBoston Scientific12 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Laborie10 shared keywordsLaborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.
Bioworld9 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Cqmedical8 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Companies competing with Levee Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Levee Medical do?
- Levee Medical develops the Voro Urologic Scaffold, an absorbable medical device designed to reduce urinary incontinence in men following radical prostatectomy for prostate cancer. The device is in the research and development phase and not yet approved for sale.
- How much funding has Levee Medical raised?
- Levee Medical has disclosed $28.3M raised across 5 rounds.
- Where is Levee Medical headquartered?
- Levee Medical is headquartered in Durham, US.